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Abstract
Background: Cancer metastasis is a multi-step event including epithelial-to-mesenchymal transition (EMT). Breast
cancer metastasis suppressor 1 (BRMS1) is a novel metastasis suppressor protein without anti-proliferating activity.
However, a detailed underlying mechanism by which BRMS1 attenuates cancer cell EMT and invasion remained to
be answered. In the present study, we report an additional mechanism by which BRMS1 attenuates Transforming
growth factor-beta1 (TGF-β1)-induced breast cancer cell EMT and invasion.
Methods: Experimental analysis involving chromosome immunoprecipitation (ChIP) and luciferase reporter assays
were used to validate hypoxia inducible factor-1alpha (HIF-1α) as a transcriptional regulator of TWIST1 and Snail.
Quantitative RT-PCR was used to analyze transcript expression. Immunoblotting and immunofluorescence were
used to analyze protein expression. Matrigel-coated in vitro invasion insert was used to analyze cancer cell invasion.
Results: BRMS1 strongly inhibited TGF-β1-induced breast cancer cell EMT and invasion. Unexpectedly, we observed
that BRMS1 downregulates not only TWIST1 but also Snail expression, thereby inhibiting breast cancer cell invasion.
In addition, we provide evidence that HIF-1α is required for Snail and TWIST1 expression. Further, BRMS1 reduced
TGF-β1-induced HIF-1α transcript expression through inactivation of nuclear factor kappaB (NF-κB).
Conclusion: Collectively, the present study demonstrates a mechanical cascade of BRMS1 suppressing cancer cell
invasion through downregulating HIF-1α transcript and consequently reducing Snail and TWIST1 expression.
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Background
Cancer metastasis is a multi-step event including epithelial-
to-mesenchymal transition (EMT) [1]. To start invading
surround extracellular matrix, tumor cells should be
detached from the neighboring epithelial cells by redu-
cing the expression of E-cadherin. Hypoxic condition
and various growth factors including transforming
growth factor-beta1 (TGF-β1) and epidermal growth
factor (EGF) have been shown to induce EMT through
upregulating the expression of transcription factors
Snail and TWIST1 [2–4].
Breast cancer metastasis suppressor 1 (BRMS1) is a
novel metastasis suppressor protein initially identified
by differential display to compare highly metastatic
breast carcinoma cells with related but metastasis-
suppressed cells [5]. BRMS1 is a part of a family that
includes suppressor of defective silencing 3 (SUDS3 or
mSds3) and BRMS1-like (BRMS1L or p40) [6, 7] and
has been shown to selectively suppress metastasis with-
out any inhibition of tumorigenicity of multiple human
cancer cells including melanoma [8], ovarian cancer [9]
and non-small cell lung cancer [10]. Accumulating evi-
dence suggests two important mechanisms for suppres-
sion of BRMS1-induced cancer metastasis: interaction
with chromatin remodeling and inhibition of nuclear
factor-kappaB (NF-κB) activity [11]. BRMS1 recruits
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histone deacetylase1 (HDAC1) to NF-κB consensus bind-
ing regions [12, 13] and upregulates miR-146a, leading to
downregulation of EGFR expression in breast cancer cells
[14]. In addition, BRMS1 was reported to have E3 ligase
function, leading to suppressing lung metastasis [15].
Recent studies suggest that BRMS1 suppresses breast
cancer cell metastasis through modulating cancer cell
EMT. Loss of BRMS1 promotes EMT through NF-κB-
dependent-TWIST1 expression [16]. Further, Gong et al.
[17] claimed that BRMS1 epigenetically silences a recep-
tor for Wnt signaling FZD10, leading to suppress breast
cancer cell EMT. However, detailed underlying mechan-
ism by which BRMS1 attenuates cancer cell EMT has not
been fully characterized. In the present study, we observed
that BRMS1 efficiently inhibited TGF-β1-induced breast
cancer cell EMT and invasiveness by downregulating not
only TWIST1 but also Snail expression. In addition, we
provide evidence that NF-κB is implicated in TGF-β1-
induced hypoxia inducible factor-1alpha (HIF-1α) expres-
sion and subsequent Snail and TWIST1 expression. Fur-
ther, the present study shows that BRMS1 significantly
inhibits TGF-β1-induced HIF-1α transcript, leading to
downregulation of Snail and TWIST1. Therefore, our re-
sults identify mechanism by which BRMS1 attenuates
cancer cell progression through downregulating HIF-1α
and subsequently reducing Snail and TWIST1 expression.
Methods
Reagents
TGF-β1 was obtained from R&D systems (Minneapolis,
MN). BAY11-7082 was purchased from Calbiochem (La
Jolla, CA). The pcDNA3-BRMS1 plasmid was generated
by subcloning EcoRI/XhoI from pOTB7-BRMS1 (clone
ID: hMU011011, KRIBB, Korea). The empty pcDNA3
vector was used as a negative control.
Cell culture
All breast cancer cell lines were purchased from American
Type Culture Collection (Manassas, VA). MDA-MB-231
were maintained in RPMI 1640 supplemented with 10 %
fetal bovine serum (FBS) and 1 % penicillin/streptomycin.
MCF-7 cells were maintained in Dulbecco’s modified
Eagle’s medium, supplemented with 10 % fetal bovine
serum and 1 % penicillin/streptomycin. All cells were
incubated at 37 °C under 5 % CO2 in a humidified
incubator.
Small interfering RNA (siRNA)
siRNAs of HIF-1α was obtained from Sigma-Aldrich (St.
Louis, MO). Control scrambled-siRNA was obtained from
Invitrogen (Carlsbad, CA). Transfection was performed by
utilizing Lipofectamine RNAiMAX (Invitrogen, Carlsbad,
CA) according to the manufacturer’s instructions.
Quantitative RT-PCR
Total cellular RNA was isolated from cultured cells using
Trizol (Invitrogen, Carlsbad, CA), and 1 μg of RNA was
reverse transcribed using oligo (dT) and M-MLV reverse
transcriptase (Promega, Madison, WI) according to the
manufacturer’s protocol. Reactions were performed as de-
scribed previously [18]. The primer sequences of mutants
are shown below. HIF-1α; forward 5’-GTT TAC TAA
AGG ACA AGT CAC C-3’ and reverse 5’-TCC TGT
TTG TTG AAG GGA G-3’, TWIST1; forward 5’-GTC
CGC AGT CTT ACG AGG AG-3’ and reverse 5’-CCA
GCT TGA GGG TCT GAATC-3’, E-cadherin; forward 5’-
ACA GCC CCG CCT TAT GAT T-3’ and reverse 5’-TCG
GAA CCG CTT CCT TCA-3’, Snail; forward 5’-TTT ACC
TTC CAG CAG CCC TA-3’ and reverse 5’-GGA CAG
AGT CCC AGA TGA GC-3’, Slug; forward 5’-TCT GCA
GAC CCA TTC TGA TG-3’ and reverse 5’-AGC AGC
CAG ATT CCT CAT GT-3’, GAPDH; forward 5’-ACA
GTC AGC CGC ATC TTC TT-3’ and reverse 5’-ACG
ACC AAATCC GTT GAC TC-3’.
Immunoblotting
The cell lysates were prepared as described [19]. Anti-
bodies for HIF-1α (1:1000), p-p65 (1:1000), Snail (1:1000)
and Slug (1:1000) were from Cell Signaling Technology
(Danvers, MA). Antibodies for E-cadherin (1:1000),
TWIST1 (1:1000), BRMS1 (1:500), p52 (1:500), p50
(1:1000) and GAPDH (1:3000) were from Santa Cruz Bio-
technology Inc. (Santa Cruz, CA). Antibody for p65
(1:1000) was obtained from BD Biosciences (San Jose,
CA). Secondary antibodies for anti-rabbit (1:2000 ~
5000) and anti-mouse (1:2000) were Thermo Fisher
Scientific Inc (Rockford, IL). Secondary antibody for
anti-goat (1:3000) obtained from Santa Cruz Biotech-
nology Inc. (Santa Cruz, CA). The immunoreactive
bands were visualized by ECL (Thermo Fisher Scien-
tific Inc., Rockford, IL) using ImageQuant 300 (GE
Healthcare, Buckinghamshire, UK).
Luciferase assay
A TWIST1 luciferase reporter vector [3] was kindly pro-
vided from Dr. Hung, MC (M.D. Anderson Cancer Cen-
ter, Houston, TX). A Snail luciferase reporter vector [20]
was kindly provided from Dr. Yook, JI (Yonsei Univer-
sity College of Medicine, Korea). A HIF-1α luciferase
reporter vector was obtained from Addgene (Cambridge,
MA). The cells were prepared in 12-well plates in tripli-
cate and transfected with the indicated reporter plasmids
by utilizing Lipofectamine 2000 reagent (Invitrogen,
Carlsbad, CA). After stimulation with or without TGF-
β1, the cells were washed twice with ice-cold PBS and
harvested with a reporter lysis buffer (Promega, Madison,
WI). The luciferase activity was analyzed as described
previously [21].
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In vitro invasion assay
In vitro invasion assay was performed with invasion assay
kit with Matrigel-coated inserts (BD Biosciences, San Jose,
CA) as described previously [22]. Volume of 1 x 106 cells/
well was added to the upper compartment of the invasion
chamber. To the lower compartment, we added serum-
free conditioned medium with or without TGF-β1. After
incubation for 12 h (MDA-MB-231) or 48 h (MCF-7) at
Fig. 1 BRMS1 inhibits TGF-β1-induced EMT. a The cells were transfected with BRMS1 or empty vector (control), and in vitro invasion was analyzed
against TGF-β1 (5 ng/ml) (***P < 0.001 vs control, ##P < 0.01 and ###P < 0.001 vs control with TGF-β1). All images original magnification, x200. b The
MCF-7 cells were transfected with BRMS1 or empty vector (control) and then treated with TGF-β1 (5 ng/ml) for indicated times. The morphology
of the cells was examined under light microscope. All images original magnification, x200. c The MCF-7 cells were transfected with BRMS1 or
empty vector (control) for 48 h and then stimulated with TGF-β1 (5 ng/ml) for 6 h. The cells were fixed and stained to assess expression of E-cadherin
(green; E-cadherin, blue; Nuclei). All images original magnification, x200. d The MCF-7 cells were transfected with BRMS1 or empty vector (control) for
48 h, followed by stimulation with TGF-β1 (5 ng/ml) for 6 h. The E-cadherin transcript was analyzed by quantitative RT–PCR. Relative mRNA levels
normalized to the expression of the housekeeping gene, GAPDH (**P < 0.01 vs control, #P < 0.05 vs control with TGF-β1). Representative results were
presented from at least three independent experiments with similar results
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37 °C, filters were fixed and stained with Diff-Quik re-
agents (Dade Behring, Inc., Newark, DE). The average
numbers of six random microscopic fields (x200) was re-
corded in each experiment.
Immunofluorescence
Immunofluorescence assays were performed as described
previously [23]. Antibodies for E-cadherin (1:100) and
HIF-1α (1:50) were obtained from BD Biosciences (San
Jose, CA). The cells were examined by confocal micros-
copy (LSM710; Carl Zeiss, Jena, Germany).
Chromatin immunoprecipitation
The ChIP assay was performed as described in the
protocol from the Millipore ChIP Assay Kit (Upstate
Biotechnology, Charlottesville, VA). Antibody for HIF-
1α was obtained from Abcam (Cambridge, MA). The
promoter-specific primers used were: TWIST1-HRE;
forward 5’-GGA CTG GAA AGC GGA AAC TT-3’
and reverse 5’-CGA GGT GTC TGG GAG TTG G-3’,
Snail-HRE; forward 5’-GCT GGG CCA GGC TGC
TTT GCA-3’ and reverse 5’-GGA CAC CTG ACC
TTC CGA CG-3’.
Subcellular fractionation
The cells were fractionated using the ProteoExtract Sub-
cellular Proteome Extraction Kit (Calbiochem, La Jolla,
CA) according to the manufacturer’s instructions. The
fractionated samples were analyzed by Immunoblotting.
Fig. 2 BRMS1 inhibits Snail and TWIST1 expression. a The cells were transfected with BRMS1 or empty vector (control) for 48 h and then
stimulated with TGF-β1 (5 ng/ml) for 6 h. Quantitative RT–PCR. Relative mRNA levels normalized to the expression of the housekeeping gene,
GAPDH (*P < 0.05 and ***P < 0.001 vs control, #P < 0.05 and ##P < 0.01 vs control with TGF-β1). b The MDA-MB-231 cells were transfected with
BRMS1 or empty vector (control) for 48 h and then stimulated with TGF-β1 (5 ng/ml) for 6 h. Immunoblotting. c and d The MDA-MB-231 cells
were cotransfected with the empty vector (control), BRMS1 and indicated reporter plasmids for 48 h, followed by stimulation with TGF-β1 (5 ng/ml)
for 24 h. Luciferase activity (**P < 0.01 and ***P < 0.001 vs control,##P < 0.01 vs control with TGF-β1). Representative results were presented from at least
three independent experiments with similar results
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Statistics
Data are shown as means ± s.d. Differences between two
groups were assessed using the Student’s t-test. Differ-
ences among three or more groups were evaluated by
analysis of variance, followed by Bonferroni multiple
comparison tests.
Results
BRMS1 inhibits breast cancer cell EMT
Given that BRMS1 has been known to attenuate cancer
cell metastasis, we first determined whether BRMS1
inhibits TGF-β1-induced breast cancer cell invasion.
Indeed, ectopic expression of BRMS1 significantly inhib-
ited TGF-β1-induced breast cancer cell invasion (Fig. 1a).
Since EMT process is important for cancer cell invasion,
we next determined whether BRMS1 regulates breast
cancer cell EMT. Stimulation of the cells with TGF-β1
efficiently induced morphological change from epithelial
to mesenchymal phenotype of breast cancer cells (Fig. 1b).
However, overexpression of BRMS1 strongly inhibited
TGF-β1-induced EMT. In addition, immunofluorescence
analysis showed that BRMS1 restored E-cadherin expres-
sion downregulated by TGF-β1 (Fig. 1c). Consistent with
these findings, we observed that BRMS1 efficiently inhib-
ited TGF-β1-induced reduction of E-cadherin transcript
(Fig. 1d). Therefore, these data strongly suggest that
BRMS1 inhibits TGF-β1-induced breast cancer cell EMT.
BRMS1 inhibits Snail and TWIST1 expression
We next determined the underlying mechanism by
which BRMS1 inhibits TGF-β1-induced breast cancer
cell EMT. Stimulation of the cells with TGF-β1 signifi-
cantly induced mRNA expression of EMT factors Snail,
Slug and TWIST1 (Fig. 2a). However, overexpression of
BRMS1 markedly inhibited Snail and TWIST1 but not
Slug transcript (Fig. 2a). Immunoblotting analysis also
showed that BRMS1 decreased TGF-β1-induced Snail
and TWIST1 expression (Fig. 2b). In addition, BRMS1
significantly inhibited TGF-β1-induced promoter activ-
ities of Snail (Fig. 2c) and TWIST1 (Fig. 2d), confirming
that BRMS1 reduces not only TWIST1 but also Snail
expression. Therefore, these results strongly suggest
that BRMS1 attenuates TGF-β1-induced breast cancer
cell EMT through downregulation of both Snail and
TWIST1.
HIF-1α is important for both Snail and TWIST1 expression
Since hypoxia increased Snail [24] and TWIST1 [2] ex-
pression, we next determined whether HIF-1α is impli-
cated in TGF-β1-induced Snail and TWIST1expression in
breast cancer cells. Stimulation of the cells with TGF-β1
significantly upregulated Snail and TWIST1 expression,
while E-cadherin expression was reduced (Fig. 3a). How-
ever, silencing HIF-1α showed opposite effects. HIF-1α
siRNA reduced both Snail and TWIST1 expression con-
comitant with increased E-cadherin (Fig. 3a). Consistently,
silencing HIF-1α abrogated TGF-β1-induced breast can-
cer cell invasion (Fig. 3b). Therefore, these data strongly
suggest that HIF-1α is important for TGF-β1-induced
Snail and TWIST1 expression and cancer cell invasion.
BRMS1 inhibits HIF-1α expression
Given that BRMS1 inhibits Snail and TWIST1 expression
and that hypoxic condition induces Snail [24] and TWIST1
[2] expression in breast cancer cells, we hypothesized that
BRMS1 inhibits HIF-1α expression. Indeed, overexpression
of BRMS1 strongly inhibited TGF-β1-induced HIF-1α
mRNA expression (Fig. 4a). In addition, ectopic expression
Fig. 3 HIF-1α is important for TGF-β1-induced Snail expression. a The cells were transfected with indicated siRNAs and then stimulated with or
without TGF-β1 (5 ng/ml) for 6 h. Immunoblotting. b The cells were transfected with indicated siRNAs and in vitro invasion was analyzed against
TGF-β1 (5 ng/ml) (**P < 0.01 and ***P < 0.001 vs control scrambled siRNA, ###P < 0.001 vs control scrambled siRNA with TGF-β1). Representative
results were presented from at least three independent experiments with similar results
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of BRMS1 significantly reduced TGF-β1-induced promoter
activities of HIF-1α (Fig. 4b). We also observed that
BRMS1 strongly reduced TGF-β1-induced HIF-1α ex-
pression (Fig. 4c). In addition, immunofluorescence
analysis showed that BRMS1 downregulated TGF-β1-
induced HIF-1α expression (Fig. 4d). Further, we ob-
served that BRMS1 abrogated TGF-β1-induced binding of
HIF-1α on a promoter region of Snail [25] and TWIST1
[26] (Fig. 4e). Together, these results suggest that BRMS1
inhibits TGF-β1-induced HIF-1α expression and subse-
quent Snail and TWIST1 expression.
NF-κB is important for HIF-1α expression
Since NF-κB is one of important transcription factors
for HIF-1α transcript [27], we next determined whether
NF-κB is important for HIF-1α transcript expression.
TGF-β1 induced translocation of NF-κB subunits from
cytosol to nucleus (Fig. 5a). However, BRMS1 strongly
inhibited TGF-β1-induced translocation of NF-κB sub-
units. In addition, pretreatment of the cells with a pharma-
cological inhibitor of NF-κB, BAY11-7082 markedly
inhibited TGF-β1-induced HIF-1α promoter activity
(Fig. 5b). Further, BAY11-7082 abrogated TGF-β1-induced
Fig. 4 BRMS1 inhibits TGF-β1-induced HIF-1α expression. a The cells were transfected with BRMS1 or empty vector (control) for 48 h and then
stimulated with TGF-β1 (5 ng/ml) for 6 h. HIF-1α mRNA expression was analyzed by quantitative RT–PCR. Relative HIF-1α mRNA levels normalized
to the expression of the housekeeping gene, GAPDH (*P < 0.05 and **P < 0.01 vs control, #P < 0.05 and ##P < 0.01 vs control with TGF-β1). b The
MDA-MB-231 cells were co-transfected with the empty vector (control), BRMS1 and HIF-1α reporter plasmids for 48 h, followed by stimulation
with TGF-β1 (5 ng/ml) for 24 h. Luciferase activity (**P < 0.01 vs control, ##P < 0.01 vs control with TGF-β1). c The MDA-MB-231 cells were transfected
with BRMS1 or empty vector (control) for 48 h and then stimulated with TGF-β1 (5 ng/ml) for 6 h. Immunoblotting. d The MDA-MB-231 cells were
sequentially transfected with indicated vectors for 48 h and then stimulated with TGF-β1 (5 ng/ml) for 6 h. The cells were fixed and stained to assess
expression of HIF-1α. e The MDA-MB-231 cells were transfected with indicated vectors before TGF-β1 (5 ng/ml) treatment. The ChIP assay was
performed as described in Materials and Methods. Representative results were presented from at least three independent experiments with similar results
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HIF-1α and TWIST1 expression (Fig. 5c). Therefore, these
data strongly suggest that NF-κB is implicated in HIF-1α
expression and consequent Snail and TWIST1 expression.
Discussion
In our current study, we elucidate the underlying mech-
anism by which BRMS1 attenuates breast cancer cell
invasion. We demonstrate that both Snail and TWIST1
are important for TGF-β1-induced breast cancer cell in-
vasion. Strikingly, our present data show that BRMS1
downregulates not only TWIST1 but also Snail expres-
sion, thereby attenuating TGF-β1-induced breast cancer
cell EMT and invasion. Moreover, our data show that
HIF-1α mediates TGF-β1-induced Snail and TWIST1
expression and that BRMS1 inactivates NF-κB to reduce
HIF-1α transcript, leading to downregulation of TGF-
β1-induced Snail and TWIST1 expression. These finding
suggest a critical role of HIF-1α through NF-κB activa-
tion in TGF-β1-induced Snail and TWIST1 expression
and their inhibition by BRMS1 for suppressing breast
cancer progression.
BRMS1 has been known to attenuate TWIST1 ex-
pression [11, 28]. More recently, Liu et al. [16] pro-
posed that BRMS1 suppresses TWIST1 expression and
subsequent NSCLC metastasis. In the present study, we
provide evidence that in addition to TWIST1, BRMS1
attenuates breast cancer cell invasion through down-
regulating Snail expression. First, BRMS1 inhibits TGF-
β1-induced Snail and TWIST1 but not Slug expression.
Second, silencing either Snail or TWIST1 expression
recovered TGF-β1-induced E-cadherin expression and
breast cancer cell EMT. More importantly, Snail siRNA
significantly inhibited TGF-β1-induced breast cancer
cell invasion.
Fig. 5 NF-κB is important for HIF-1α expression. a The cells were transfected with BRMS1 or empty vector (control) for 48 h and then stimulated
with TGF-β1 (5 ng/ml) for 6 h. Immunoblotting. b The MDA-MB-231 cells transfected with a luciferase vector containing a HIF-1α promoter were
pretreated with BAY11-7082 (5 μM) for 1 h, followed by stimulation with TGF-β1 (5 ng/ml) for 24 h. Luciferase activity (*P < 0.05 vs DMSO, ##P < 0.01 vs
TGF-β1 treatment only). c The serum-starved MDA-MB-231 cells were pretreated with BAY11-7082 (5 μM) for 1 h and then stimulated with TGF-β1
(5 ng/ml) for 6 h. Immunoblotting. Representative results were presented from at least three independent experiments with similar results
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HIF-1α induced by hypoxia and growth factors has
been shown to mediate EMT and metastasis of various
cancer cells. HIF-1α was reported to upregulate TWIST1
expression to induce morphological change of epithelial
cells to mesenchymal phenotype [2]. In addition, our
recent results suggest that HIF-1α is important for
TWIST1 expression and prostate cancer cell invasion
[23, 26]. Further, recent study shows that HIF-1α induces
histone deacetylase 3 (HDAC3) which in turn cooperate
with Snail to induce EMT and metastatic phenotypes [29].
Consistent with these notions, we demonstrated in the
present study that TGF-β1 induces HIF-1α expression,
which in turn upregulates TWIST1 expression. Notably,
we observed that HIF-1α is also implicated in Snail ex-
pression in breast cancer cells which was not detected in
prostate cancer cells [23], suggesting the differential role
of HIF-1α in Snail expression depending on the cellular
context. Consistent with this notion, tumor hypoxia corre-
lates with overexpression of HIF-1α, and consequently
with TWIST and Snail expression [2]. Since Snail has
been known to enhance TWIST1 protein stability in
mouse breast epithelial NMuMG cells [30], further
study to explore the crosslink between Snail and TWIST1
expression is warranted to determine the underlying
mechanism of TGF-β1-induced breast cancer cell EMT
and aggressiveness.
Conclusion
Our results demonstrate that BRMS1 attenuates TGF-β1-
induced breast cancer cell invasion through inhibition of
NF-κB and subsequent reduction of HIF-1α expression
required for Snail and TWIST1 expression, uncovers a
new mechanism through which BRMS1 suppresses breast
cancer progression.
Abbreviations
BRMS1: breast cancer metastasis suppressor 1; EMT: epithelial-to-mesenchymal
transition; TGF-ß1: transforming growth factor beta 1; EGF: epidermal growth
factor; HIF-1α: hypoxia-inducible factor 1alpha; NF-κB: nuclear factor-kappaB;
siRNA: Small interfering RNA; ChIP: Chromatin immunoprecipitation.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KHY, CGP and HYL designed the experiments. KHC, SLY and DYC performed
the experiments. KHC, SLY and DYC analyzed the data. KHY and HYL wrote
the manuscript. All the authors approved the final draft of this manuscript.
All authors read, edited and approved the final version of this manuscript.
Acknowledgements
This study was supported by a grant from the National R&D Program for
Cancer Control, Ministry of Health & Welfare, Republic of Korea (121182) and
Basic Science Research Program through the National Research Foundation
of Korea (NRF) funded by the Ministry of Education, Science and Technology
(2013R1A1A2A10059565, 2014R1A2A1A11051091).
Author details
1Department of Pharmacology, Myunggok Medical Institute, College of
Medicine, Konyang University, Daejeon, Republic of Korea. 2Department of
Hematology & Oncology, Myunggok Medical Institute, College of Medicine,
Konyang University, Daejeon, Republic of Korea.
Received: 6 May 2015 Accepted: 27 October 2015
References
1. Tomaskovic-Crook E, Thompson EW, Thiery JP. Epithelial to mesenchymal
transition and breast cancer. Breast Cancer Res. 2009;11(6):213.
2. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, et al. Direct
regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol.
2008;10(3):295–305.
3. Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei Y, et al. Epidermal growth factor
receptor cooperates with signal transducer and activator of transcription 3
to induce epithelial-mesenchymal transition in cancer cells via up-regulation
of TWIST gene expression. Cancer Res. 2007;67(19):9066–76.
4. Oft M, Peli J, Rudaz C, Schwarz H, Beug H, Reichmann E. TGF-beta1 and
Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness
of epithelial tumor cells. Genes Dev. 1996;10(19):2462–77.
5. Seraj MJ, Samant RS, Verderame MF, Welch DR. Functional evidence for a
novel human breast carcinoma metastasis suppressor, BRMS1, encoded at
chromosome 11q13. Cancer Res. 2000;60(11):2764–9.
6. Silveira AC, Hurst DR, Vaidya KS, Ayer DE, Welch DR. Over-expression of the
BRMS1 family member SUDS3 does not suppress metastasis of human
cancer cells. Cancer Lett. 2009;276(1):32–7.
7. Nikolaev AY, Papanikolaou NA, Li M, Qin J, Gu W. Identification of a novel
BRMS1-homologue protein p40 as a component of the mSin3A/
p33(ING1b)/HDAC1 deacetylase complex. Biochem Biophys Res Commun.
2004;323(4):1216–22.
8. Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ,
et al. Suppression of human melanoma metastasis by the metastasis
suppressor gene, BRMS1. Exp Cell Res. 2002;273(2):229–39.
9. Zhang S, Lin QD, Di W. Suppression of human ovarian carcinoma metastasis
by the metastasis-suppressor gene, BRMS1. Int J Gynecol Cancer.
2006;16(2):522–31.
10. Smith PW, Liu Y, Siefert SA, Moskaluk CA, Petroni GR, Jones DR. Breast
cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and
correlates with improved patient survival in non-small cell lung cancer.
Cancer Lett. 2009;276(2):196–203.
11. Hurst DR, Welch DR. Unraveling the enigmatic complexities of
BRMS1-mediated metastasis suppression. FEBS Lett. 2011;585(20):3185–90.
12. Cicek M, Fukuyama R, Cicek MS, Sizemore S, Welch DR, Sizemore N, et al.
BRMS1 contributes to the negative regulation of uPA gene expression
through recruitment of HDAC1 to the NF-kappaB binding site of the uPA
promoter. Clin Exp Metastasis. 2009;26(3):229–37.
13. Liu Y, Smith PW, Jones DR. Breast cancer metastasis suppressor 1 functions
as a corepressor by enhancing histone deacetylase 1-mediated
deacetylation of RelA/p65 and promoting apoptosis. Mol Cell Biol.
2006;26(23):8683–96.
14. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast
cancer metastasis suppressor 1 up-regulates miR-146, which suppresses
breast cancer metastasis. Cancer Res. 2009;69(4):1279–83.
15. Liu Y, Mayo MW, Nagji AS, Hall EH, Shock LS, Xiao A, et al. BRMS1
suppresses lung cancer metastases through an E3 ligase function on
histone acetyltransferase p300. Cancer Res. 2013;73(4):1308–17.
16. Liu Y, Mayo MW, Xiao A, Hall EH, Amin EB, Kadota K, et al. Loss of BRMS1
Promotes a Mesenchymal Phenotype through NF-kappaB-Dependent
Regulation of Twist1. Mol Cell Biol. 2015;35(1):303–17.
17. Gong C, Qu S, Lv XB, Liu B, Tan W, Nie Y, et al. BRMS1L suppresses breast
cancer metastasis by inducing epigenetic silence of FZD10. Nat Commun.
2014;5:5406.
18. Choi MJ, Cho KH, Lee S, Bae YJ, Jeong KJ, Rha SY, et al. hTERT mediates
norepinephrine-induced Slug expression and ovarian cancer aggressiveness.
Oncogene. 2015;34(26):3402–12.
19. Lee J, Park SY, Lee EK, Park CG, Chung HC, Rha SY, et al. Activation of
hypoxia-inducible factor-1alpha is necessary for lysophosphatidic
acid-induced vascular endothelial growth factor expression. Clin
Cancer Res. 2006;12(21):6351–8.
20. Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim NH, et al. A Wnt-Axin2-GSK3beta
cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol.
2006;8(12):1398–406.
Cho et al. BMC Cancer  (2015) 15:829 Page 8 of 9
21. Jeong KJ, Park SY, Cho KH, Sohn JS, Lee J, Kim YK, et al. The Rho/ROCK
pathway for lysophosphatidic acid-induced proteolytic enzyme expression
and ovarian cancer cell invasion. Oncogene. 2012;31:4279–89.
22. Mertens PR, Harendza S, Pollock AS, Lovett DH. Glomerular mesangial
cell-specific transactivation of matrix metalloproteinase 2 transcription is
mediated by YB-1. J Biol Chem. 1997;272(36):22905–12.
23. Cho KH, Choi MJ, Jeong KJ, Kim JJ, Hwang MH, Shin SC, et al. A ROS/STAT3/
HIF-1alpha signaling cascade mediates EGF-induced TWIST1 expression and
prostate cancer cell invasion. Prostate. 2014;74(5):528–36.
24. Lundgren K, Nordenskjold B, Landberg G. Hypoxia, Snail and incomplete
epithelial-mesenchymal transition in breast cancer. Br J Cancer.
2009;101(10):1769–81.
25. Zhu GH, Huang C, Feng ZZ, Lv XH, Qiu ZJ. Hypoxia-induced snail expression
through transcriptional regulation by HIF-1alpha in pancreatic cancer cells.
Dig Dis Sci. 2013;58(12):3503–15.
26. Cho KH, Jeong KJ, Shin SC, Kang J, Park CG, Lee HY. STAT3 mediates
TGF-beta1-induced TWIST1 expression and prostate cancer invasion.
Cancer Lett. 2013;336(1):167–73.
27. Tsapournioti S, Mylonis I, Hatziefthimiou A, Ioannou MG, Stamatiou R,
Koukoulis GK, et al. TNFalpha induces expression of HIF-1alpha mRNA and
protein but inhibits hypoxic stimulation of HIF-1 transcriptional activity in
airway smooth muscle cells. J Cell Physiol. 2013;228(8):1745–53.
28. Edmonds MD, Hurst DR, Welch DR. Linking metastasis suppression with
metastamiR regulation. Cell Cycle. 2009;8(17):2673–5.
29. Wu MZ, Tsai YP, Yang MH, Huang CH, Chang SY, Chang CC, et al.
Interplay between HDAC3 and WDR5 is essential for hypoxia-induced
epithelial-mesenchymal transition. Mol Cell. 2011;43(5):811–22.
30. Dave N, Guaita-Esteruelas S, Gutarra S, Frias A, Beltran M, Peiro S, et al.
Functional cooperation between Snail1 and twist in the regulation of ZEB1
expression during epithelial to mesenchymal transition. J Biol Chem.
2011;286(14):12024–32.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Cho et al. BMC Cancer  (2015) 15:829 Page 9 of 9
